Spain - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain - 2023
Contents:
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (CIF) - 2022
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (FOB) - 2023
- Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain
- Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (CIF) - 2022
The average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $86,414 per ton in 2022, surging by 42% against the previous year. In general, the import price saw strong growth. The growth pace was the most rapid in 2018 when the average import price increased by 170%. Over the period under review, average import prices attained the maximum at $88,470 per ton in 2019; however, from 2020 to 2022, import prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($195,636 per ton), while the price for the UK ($22,753 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Italy (+32.9%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (FOB) - 2023
In August 2023, the average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $72,257 per ton, waning by -17.2% against the previous month. In general, export price indicated a noticeable increase from August 2022 to August 2023: its price increased at an average monthly rate of +3.2% over the last twelve-month period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on August 2023 figures, export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by -18.4% against June 2023 indices. The most prominent rate of growth was recorded in April 2023 an increase of 170% against the previous month. The export price peaked at $88,603 per ton in June 2023; however, from July 2023 to August 2023, the export prices remained at a lower figure.
Prices varied noticeably by the country of destination: the country with the highest price was Germany ($112K per ton), while the average price for exports to Romania ($33,717 per ton) was amongst the lowest.
From August 2022 to August 2023, the most notable rate of growth in terms of prices was recorded for supplies to Romania (+13.8%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain
In 2022, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses into Spain soared to 8.3K tons, picking up by 15% on 2021. Overall, total imports indicated resilient growth from 2019 to 2022: its volume increased at an average annual rate of +11.6% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -8.7% against 2020 indices. The most prominent rate of growth was recorded in 2020 when imports increased by 52% against the previous year. As a result, imports attained the peak of 9.1K tons. From 2021 to 2022, the growth of imports of remained at a lower figure.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses soared to $718M in 2022. In general, total imports indicated a prominent expansion from 2019 to 2022: its value increased at an average annual rate of +10.7% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, imports attained the peak and are likely to continue growth in the immediate term.
Import of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
Switzerland | 4.6 | 295 | 167 | 438 | 356.6% |
Germany | 42.0 | 70.7 | 78.5 | 58.0 | 11.4% |
Croatia | 11.3 | 16.0 | 22.3 | 43.0 | 56.1% |
Netherlands | 69.5 | 50.8 | 52.4 | 28.5 | -25.7% |
Poland | 9.7 | 17.9 | 20.6 | 23.0 | 33.3% |
China | 7.9 | 10.4 | 7.3 | 20.2 | 36.7% |
Ireland | 15.2 | 17.3 | 15.3 | 19.4 | 8.5% |
India | 7.2 | 7.0 | 14.3 | 18.5 | 37.0% |
Hungary | 10.0 | 16.3 | 20.1 | 17.3 | 20.0% |
France | 11.8 | 10.8 | 8.7 | 7.5 | -14.0% |
Belgium | 2.4 | 0.3 | 2.0 | 5.8 | 34.2% |
United Kingdom | 4.6 | 7.7 | N/A | N/A | 67.4% |
Others | 333 | 24.8 | 29.9 | 38.8 | -51.2% |
Total | 529 | 546 | 439 | 718 | 10.7% |
Top Suppliers of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses to Spain in 2022:
- Switzerland (3499.2 tons)
- Germany (1358.2 tons)
- China (726.9 tons)
- India (712.6 tons)
- Croatia (368.9 tons)
- France (299.1 tons)
- Poland (250.9 tons)
- Ireland (246.9 tons)
- Netherlands (166.3 tons)
- Hungary (164.9 tons)
- Belgium (144.4 tons)
- United Kingdom (1.4 tons)
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain
In 2022, overseas shipments of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by -4.6% to 9.7K tons, falling for the second year in a row after two years of growth. Over the period under review, exports saw a abrupt decrease. The pace of growth appeared the most rapid in 2020 when exports increased by 9.3% against the previous year. As a result, the exports attained the peak of 14K tons. From 2021 to 2022, the growth of the exports of failed to regain momentum.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses rose slightly to $604M in 2022. The total export value increased at an average annual rate of +4.3% over the period from 2019 to 2022; however, the trend pattern remained relatively stable, with only minor fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2020 when exports increased by 14%. As a result, the exports reached the peak of $607M. From 2021 to 2022, the growth of the exports of failed to regain momentum.
Export of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Spain (Million USD) | |||||
---|---|---|---|---|---|
COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
Germany | 90.1 | 118 | 129 | 160 | 21.1% |
Italy | 81.9 | 76.0 | 83.9 | 82.9 | 0.4% |
France | 40.6 | 53.3 | 44.5 | 56.7 | 11.8% |
Netherlands | 28.9 | 30.2 | 58.9 | 35.6 | 7.2% |
Poland | 15.9 | 19.7 | 24.5 | 23.9 | 14.6% |
Sweden | 13.6 | 18.0 | 20.6 | 22.7 | 18.6% |
Czech Republic | 16.2 | 20.6 | 22.3 | 22.4 | 11.4% |
Portugal | 13.7 | 20.6 | 21.0 | 22.0 | 17.1% |
Denmark | 13.3 | 12.0 | 11.2 | 17.0 | 8.5% |
Ireland | 49.0 | 62.8 | 23.0 | 15.9 | -31.3% |
United States | 2.6 | 1.1 | 9.9 | 15.4 | 80.9% |
Romania | 5.6 | 7.3 | 7.9 | 13.8 | 35.1% |
Hungary | 11.9 | 11.5 | 10.6 | 13.8 | 5.1% |
Others | 149 | 156 | 111 | 102 | -11.9% |
Total | 532 | 607 | 578 | 604 | 4.3% |
Top Export Markets for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses from Spain in 2022:
- Germany (2095.4 tons)
- Italy (1341.9 tons)
- France (1083.6 tons)
- Netherlands (688.9 tons)
- Romania (505.0 tons)
- Sweden (426.2 tons)
- Denmark (387.6 tons)
- Czech Republic (368.2 tons)
- Portugal (333.0 tons)
- Poland (314.4 tons)
- United States (233.4 tons)
- Hungary (206.0 tons)
- Ireland (199.7 tons)
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Spain. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Spain
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Spain
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Spain.
This report provides an in-depth analysis of the medicaments containing hormones market in Spain.
This report provides an in-depth analysis of the medicaments containing insulin market in Spain.
This report provides an in-depth analysis of the medicaments containing penicillin market in Spain.
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Spain.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Spain.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the global medicaments containing hormones market.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the global medicaments containing penicillin market.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.